Concord Drugs Market Cap

Concord Drugs has a market cap or net worth of 961.78 million as of January 23, 2026. Its market cap has increased by 150.07% in one year.

Market Cap

961.78M

Enterprise Value

1.15B

Revenue

450.74M

Ranking

n/a

PE Ratio

126.21

Stock Price

74.16

Market Cap Chart

Since February 23, 2015, Concord Drugs's market cap has increased from 144.80M to 961.78M, an increase of 564.20%. That is a compound annual growth rate of 18.93%.

Market Cap History

Date	Market Cap	% Change
Jan 23, 2026	961.78M	-11.49%
Dec 31, 2025	1.09B	188.24%
Dec 31, 2024	377.00M	-36.87%
Dec 29, 2023	597.20M	109.83%
Dec 30, 2022	284.61M	1.24%
Dec 31, 2021	281.11M	40.39%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Lactose (India)	1.26B
Sotac Pharmaceuticals	1.16B
Bal Pharma	1.09B
Mercury Laboratories	939.60M
Source Natural Foods and Herbal Supplements	901.49M
Amwill Health Care	844.15M
Zenith Drugs	835.15M
Phaarmasia	753.36M

Market Cap Rankings